Table: Cosmos Pharmaceutical - 9-MTH group results

Cosmos Pharmaceutical

12/04/2021 07:15

Apr 12 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Feb 28, 2021        Feb 29, 2020     May 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            541.70              492.88           723.00    
                 (+9.9 pct)          (+9.4 pct)       (+5.6 pct)  
  Operating         26.01               19.43            29.10    
                 (+33.8 pct)         (+7.8 pct)       (+0.0 pct)  
  Recurring         27.86               21.20            31.60    
                 (+31.4 pct)         (+7.7 pct)       (+0.1 pct)  
  Net               21.58               14.24            21.78    
                 (+51.6 pct)         (+7.8 pct)       (+1.6 pct)  
  EPS            545.00 yen          359.59 yen       550.01 yen  
  Ann Div                            110.00 yen        55.00 yen  
  -Q2 div         27.50 yen           50.00 yen                   
  -Q4 div                             60.00 yen        27.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T